https://www.nasdaq.com/press-release/acorda-therapeutics-to-present-at-the-h.c.-wainwright-bioconnect-virtual-conference
https://www.nasdaq.com/press-release/john-varian-joins-acorda-therapeutics-board-of-directors-2022-01-03
https://www.nasdaq.com/press-release/acorda-therapeutics-announces-agreement-to-commercialize-inbrijar-in-germany-2021-11
https://www.nasdaq.com/press-release/acorda-therapeutics-reports-third-quarter-2021-financial-results-additions-to
https://www.nasdaq.com/press-release/acorda-third-quarter-2021-update%3a-webcast-scheduled-for-november-9-2021-2021-11-02
https://www.nasdaq.com/press-release/acorda-therapeutics-announces-corporate-restructuring-management-changes-2021-09-09
https://www.nasdaq.com/press-release/acorda-therapeutics-reports-second-quarter-2021-financial-results-2021-08-05
https://www.nasdaq.com/press-release/acorda-second-quarter-2021-update%3a-webcast-conference-call-scheduled-for-august-5
https://www.nasdaq.com/press-release/acorda-second-quarter-2021-update%3a-webcast-conference-call-scheduled-for-august-5
https://www.nasdaq.com/press-release/acorda-therapeutics-announces-agreement-to-commercialize-inbrijar-in-spain-2021-07-22
https://www.nasdaq.com/press-release/acorda-therapeutics-announces-repayment-of-convertible-senior-notes-2021-06-16
https://www.nasdaq.com/press-release/acorda-therapeutics-reports-first-quarter-2021-financial-results-2021-05-06
https://www.nasdaq.com/press-release/acorda-therapeutics-first-quarter-2021-update%3a-webcast-conference-call-scheduled-for
https://www.nasdaq.com/press-release/celebrity-chef-zarela-martinez-partners-with-acorda-therapeutics-on-the-launch-of-a
https://www.nasdaq.com/press-release/acorda-therapeutics-to-present-at-h.c.-wainwright-global-life-sciences-virtual
https://www.nasdaq.com/press-release/acorda-therapeutics-provides-business-update-and-reports-fourth-quarter-and-full-0
https://www.nasdaq.com/press-release/acorda-fourth-quarter-year-end-2020-update%3a-webcast-conference-call-scheduled-for
https://www.nasdaq.com/press-release/acorda-therapeutics-announces-departure-of-chief-business-operations-2021-02-19
https://www.nasdaq.com/press-release/acorda-therapeutics-announces-completion-of-sale-of-manufacturing-operations-to
https://www.nasdaq.com/press-release/acorda-therapeutics-announces-agreement-for-sale-of-manufacturing-operations-and-long
https://www.nasdaq.com/press-release/acorda-therapeutics-to-present-at-39th-annual-j.p.-morgan-health-care-conference-2021
https://www.nasdaq.com/press-release/acorda-therapeutics-to-present-at-h.c.-wainwright-bioconnect-virtual-conference-2021
https://www.nasdaq.com/press-release/acorda-therapeutics-announces-completion-of-one-for-six-reverse-stock-split-2020-12
https://www.nasdaq.com/press-release/acorda-reports-third-quarter-2020-financial-results-2020-11-03
https://www.nasdaq.com/press-release/acorda-third-quarter-2020-update%3a-webcast-conference-call-scheduled-for-november-3
https://www.nasdaq.com/press-release/acorda-reports-second-quarter-2020-financial-results-2020-08-04
https://www.nasdaq.com/press-release/acorda-therapeutics-announces-adjournment-of-special-meeting-of-stockholders-2020-07
https://www.nasdaq.com/press-release/acorda-second-quarter-2020-update%3a-webcast-conference-call-scheduled-for-august-4
https://www.nasdaq.com/press-release/acorda-reports-first-quarter-2020-financial-results-and-provides-business-update-2020
https://www.nasdaq.com/press-release/acorda-first-quarter-2020-update%3a-webcast-conference-call-scheduled-for-may-5-2020
https://www.nasdaq.com/press-release/acorda-therapeutics-to-present-at-cowen-annual-health-care-conference-2020-02-24
https://www.nasdaq.com/press-release/acorda-therapeutics-provides-business-update-and-reports-fourth-quarter-and-full-year
https://www.nasdaq.com/press-release/acorda-to-present-data-at-the-3rd-pan-american-parkinsons-disease-and-movement
https://www.nasdaq.com/press-release/acorda-fourth-quarter-year-end-2019-update%3a-webcast-conference-call-scheduled-for
https://www.nasdaq.com/press-release/acorda-provides-2019-highlights-and-2020-guidance-at-j.p.-morgan-healthcare
https://www.nasdaq.com/press-release/acorda-to-present-at-the-38th-annual-j.p.-morgan-healthcare-conference-2020-01-08
https://www.nasdaq.com/press-release/acorda-therapeutics-completes-exchange-of-%24276-million-of-its-1.75-convertible-senior
https://www.nasdaq.com/press-release/acorda-therapeutics-announces-private-exchange-of-%24276-million-of-its-1.75
https://www.nasdaq.com/press-release/acorda-therapeutics-elects-john-kelley-chair-board-of-directors-2019-11-27
https://www.nasdaq.com/press-release/acorda-therapeutics-announces-departure-of-president-international-general-counsel
https://www.nasdaq.com/press-release/acorda-provides-update-for-third-quarter-ended-september-30-2019-2019-11-04
https://www.nasdaq.com/press-release/acorda-therapeutics-implements-corporate-restructuring-provides-third-quarter-2019
https://www.nasdaq.com/press-release/acorda-launches-new-tool-for-people-with-parkinsons-to-improve-communication-about
https://www.nasdaq.com/press-release/acorda-third-quarter-2019-update%3a-webcast-conference-call-scheduled-for-november-4
https://www.nasdaq.com/press-release/acorda-therapeutics-to-present-at-the-2019-cantor-healthcare-conference-2019-09-25
https://www.nasdaq.com/press-release/acorda-to-present-data-at-the-international-congress-of-parkinsons-disease-and
https://www.nasdaq.com/press-release/wedbush-securities-senior-vice-president-equity-research-laura-chico-ph.d.-initiates
https://www.nasdaq.com/press-release/acorda-first-quarter-2019-update-webcastconference-call-scheduled-may-2-2019-2019-04
